LSF analogs (Islet Sciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLSF analogs (Islet Sciences)
Drug Alias NameIL-12/STAT-4 inhibitors (Islet Sciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-12 receptor inhibitorsSignal transducer and activator of transcription 4 stimulants
TargetsInterleukin-12 receptorSignal transducer and activator of transcription 4
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIslet Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIslet Sciences
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A